Kane Biotech

Kane Biotech

Actively advancing technologies and products that break up biofilms and destroy bacteria.

HQ location
Winnipeg, Canada
Launch date
Employees
Market cap
$4.9m
Enterprise value
$6m
Share price
CAD0.04 KNE.V
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*
N/A

CAD1.2m

Private Placement non VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
CAD2018201920202021202220232024
Revenues0000000000000000000000000000
% growth20 %234 %(21 %)20 %66 %(94 %)1297 %
EBITDA0000000000000000000000000000
% EBITDA margin(612 %)(202 %)(272 %)(264 %)(103 %)(2087 %)(178 %)
Profit0000000000000000000000000000
% profit margin(644 %)(57 %)(277 %)(286 %)(146 %)(3379 %)293 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue182 %91 %99 %86 %39 %707 %83 %

Source: Company filings or news article

Notes (0)
More about Kane Biotech
Made with AI
Edit

Kane Biotech Inc. is a biotechnology company focused on the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company operates in the biotechnology sector, serving clients across various industries that require biofilm management solutions, including healthcare, industrial, and consumer markets. Kane Biotech's business model revolves around developing proprietary technologies and products, which are then commercialized through partnerships, licensing agreements, and direct sales. Revenue is generated through product sales, licensing fees, and royalties from partnered products. The company leverages its extensive expertise in biofilm research to create innovative solutions that address significant challenges in biofilm management, thereby providing value to its clients and stakeholders.

Keywords: biotechnology, microbial biofilms, prevention, removal, healthcare, industrial, consumer markets, proprietary technologies, licensing, commercialization.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Kane Biotech

Edit
FB Dermatology
ACQUISITION by Kane Biotech Nov 2024